Dr. Joseph Thomas Telliard, DO

Dr. Telliard practices at Centennial Hills Hospital Medical Center in Las Vegas, Nevada.

Dr. Telliard's NPI, 1912356106, was assigned on June 8, 2016. Dr. Telliard holds Nevada license SL1151.

Dr. Telliard's primary practice is Centennial Hills Hospital Medical Center, at 6901 N Durango Dr, Las Vegas, NV 89149 in Clark County. The practice phone is (702) 894-5706.

Dr. Telliard's primary practice is Centennial Hills Hospital Medical Center in Las Vegas, Nevada. Dr. Telliard is also affiliated with Centennial Hills Hospital Medical Center. The medical group on file is Sound Physicians. Dmand AI also links Dr. Telliard to 5 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Telliard practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Telliard's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Telliard is licensed in Nevada.

CMS data shows 352 Medicare services from Dr. Telliard across 7 procedure codes in 2024, for 203 Medicare patients. Medicare paid $45,597 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 203 Medicare patients who saw Dr. Telliard in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Telliard's median patient age at 73, with 44% women.

In 2021, Dr. Telliard wrote 42 Medicare Part D claims. They cover 2 drugs, with $900 in total drug cost. In 2019, CMS named 66 claims across 4 drugs.

Dr. Telliard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 39 general payments to Dr. Telliard from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Sunovion Pharmaceuticals Inc. paid the most, $542.